Compounds and uses thereof
AssigneeFoghorn Therapeutics Inc.
InventorsSabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
Claims56
A compound having the structure of Formula I:
- A-L-B Formula I,
- wherein
- A is
- wherein
- A1 is a bond between A and L;
- R4 is H, optionally substituted C1-C6 alkyl, optionally substituted C2-C6 alkenyl, optionally substituted C1-C6 heteroalkyl, or optionally substituted C3-C10 carbocyclyl
- R5 is H, halogen, optionally substituted C1-C6 alkyl, optionally substituted C1-C6 heteroalkyl, optionally substituted C3-C10 carbocyclyl, or optionally substituted C6-C10 aryl;
- R6a is H, halogen, cyano, optionally substituted C1-C6 alkyl, optionally substituted C1-C6 heteroalkyl, optionally substituted C3-C10 carbocyclyl, optionally substituted C2-C9 heterocyclyl, optionally substituted C6-C10 aryl, optionally substituted C2-C9 heteroaryl, optionally substituted C2-C6 alkenyl, optionally substituted C2-C6 heteroalkenyl, hydroxy, thiol, or optionally substituted amino;
- R6b is H, halogen, cyano, optionally substituted C1-C6 alkyl, optionally substituted C1-C6 heteroalkyl, optionally substituted C3-C10 carbocyclyl, optionally substituted C2-C9 heterocyclyl, optionally substituted C6-C10 aryl, optionally substituted C2-C9 heteroaryl, optionally substituted C2-C6 alkenyl, optionally substituted C2-C6 heteroalkenyl, hydroxy, thiol, or optionally substituted amino, or R6a and R6b, together with the carbon atoms to which each is attached, combine to form optionally substituted C6-C10 aryl or optionally substituted C2-C9 heteroaryl;
- B is
- wherein
- A2 is a bond between B and L;
- v1 is 0, 1, 2, 3, 4, or 5;
- RA5 is H, optionally substituted C1-C5 alkyl, or optionally substituted C1-C5 heteroalkyl;
- each RJ1 is, independently, halogen, optionally substituted C1-C6 alkyl, or optionally substituted C1-C6 heteroalkyl;
- JA is absent, O, optionally substituted amino, optionally substituted C1-C5 alkyl, or optionally substituted C1-C6 heteroalkyl;
- and
- J is absent, optionally substituted C3-C10 carbocyclylene, optionally substituted C6-C10 arylene, optionally substituted C2-C9 heterocyclylene, or optionally substituted C2-C9 heteroarylene, optionally substituted amino, optionally substituted C1-C6 alkyl, or optionally substituted C1-C6 heteroalkyl;
- and
- L is
- A1-(E1)-(F1)—(C3)m-(F2)o1-A2, Formula IId
- wherein
- A1 is a bond between L and A;
- A2 is a bond between B and L;
- each of m and o1 is, independently, 0 or 1;
- O, S, NRN, optionally substituted C1-10 alkylene, optionally substituted C2-10 alkenylene, optionally substituted C2-10 alkynylene, optionally substituted C2-C10 polyethylene glycol, or optionally substituted C1-10 heteroalkylene;
- RN is H, optionally substituted C1-4 alkyl, optionally substituted C2-4 alkenyl, optionally substituted C2-4 alkynyl, optionally substituted C2-6 heterocyclyl, optionally substituted C6-12 aryl, or optionally substituted C1-7 heteroalkyl;
- C3 is carbonyl, thiocarbonyl, sulphonyl, or phosphoryl;
- and
- each of F1 and F2 is, independently, optionally substituted C3-C10 carbocyclylene, optionally substituted C2-10 heterocyclylene, optionally substituted C6-C10 arylene, or optionally substituted C2-C9 heteroarylene,
- or a pharmaceutically acceptable salt thereof.
2-17. (canceled)
(canceled)
21-30. (canceled)
32-38. (canceled)
(canceled)
42-50. (canceled)
54-77. (canceled)
79-80. (canceled)
82-116. (canceled)
118-119. (canceled)
121-128. (canceled)
130-186. (canceled)
188-199. (canceled)
202-204. (canceled)
206-208. (canceled)
210-300. (canceled)
A compound having the structure of any one of compounds D1-D259 in Table 1A, D260-D371 in Table 1B, D372-D476 in Table 1D, DD1-DD10 in Table 1C, and DD11-DD16 in Table 1E.
302-305. (canceled)
(canceled)
(canceled)
315-317. (canceled)
(canceled)
(canceled)
(canceled)
325-327. (canceled)
Dependencies are inferred from the claim text.